Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters

(Click image to play video) Avicanna Inc. ( TSX: AVCN , OTCQX: AVCNF , Forum ) is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products...
Featured Submission | April 20, 2021 |

Domo Posts 19% Growth in Q1 FY21 Revenue

Shares of cloud platform provider Domo Inc. traded 15% higher and set a new 52-week high price after the company reported Q1 FY21 financial results that included a 19% increase in y-o-y revenue. Cloud-based business platform company Domo Inc. (DOMO:NASDAQ) yester...
Streetwise Reports | June 8, 2020 |

Illumina Shares Fall Sharply on Lower Revenue Guidance

Illumina Inc. shares are trading down more than 15% today as the company reported lower preliminary Q2/19 revenues and updated its annual revenue guidance. In an announcement released this morning, Illumina Inc. (ILMN:NASDAQ) reported lower preliminary reve...
Streetwise Reports | July 16, 2019 |

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

California Gold: Two U.S. Hemp Revenue Streams Coming Online This Quarter

Peter Epstein of Epstein Research discusses recent developments at the company. On January 29th , California Gold Mining Inc. (CGM:CSE; CFGMF:OTCQB) announced an agreement with a North Carolina-based hemp-CBD extraction company for the sale of CBD isolate produc...
Streetwise Reports | January 30, 2020 |

Energy Major's Domestic Revenue Likely Lower Q1/19; Will Turn Around in Q2/19

Raymond James detailed what it expects for two of the company's business segments, domestically and internationally, in these two quarters and beyond. In an April 1 research note, analyst Praveen Narra reported that Raymond James lowered its Q1/19 domestic estimates for...
Streetwise Reports | April 5, 2019 |

eHealth Shares Up 25% as Quarterly Revenue Doubled and 2019 Guidance Raised

The prognosis for online exchange operator eHealth Inc. looks positive as the company reported a 101% increase in Q2/19 revenues over the prior year period and raised full year 2019 revenue estimates by $50 million to $365–385 million, compared with previous guidance of $315...
Streetwise Reports | July 29, 2019 |

Guardant Health Reports Quarterly Revenue Up 178%

Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180-190 million. Precision oncology company Guardant Health Inc. (GH:NASDAQ) , which focuses on helping conquer cancer ...
Streetwise Reports | August 9, 2019 |

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
Featured Submission | August 3, 2021 |

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data

Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration. Ocular Ther...
Streetwise Reports | March 5, 2020 |
1 2 3 4 5 6 7 8 9 10 ...